Optimism sweeps Latin America boosting the implementation of healthcare reform and opportunities for investment
This article was originally published in Clinica
The Latin American healthcare market is set to maintain high levels of growth and improvement in standards, heralded by the region's relative political stability, ongoing reforms, increased levels of domestic and foreign investment and positive economic indicators. This was the conclusion of speakers at the seminar of the Latin American Trade Advisory Group (LATAG), held earlier this month in Leeds, UK.
You may also be interested in...
Biopharma was an attractive investment in 2020 and fundamentals are unchanged in 2021, including the pandemic’s work-at-home requirements, which allowed more companies to go public faster.
Abbott reported almost 28% revenue growth in the fourth quarter led by the exploding demand for COVID-19 tests and continued success of its FreeStyle Libre continuous glucose monitor.
While representing a smaller population, the ACTIVATE-T trial targeted patients seen as having greater unmet need.